CIK 0001636282
- Large accelerated filer
Spyre Therapeutics, Inc.
Sign in to watch- Ticker
- SYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464312787
- Phone
- +1 617-651-5940
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aeglea BioTherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,349,597
- in 6 filings, $12.3M under 10b5-1 plans
Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 21 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-22 | Alspaugh Jonathan President and CFO | Grant or award · Employee Stock Option (right to buy) | +19,787,969 | 19,787,969 | ||
| 2023-02-23 | Alspaugh Jonathan Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +640,000 | 640,000 | ||
| 2022-08-23 | Alspaugh Jonathan Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2022-03-11 | Alspaugh Jonathan Chief Financial Officer | Purchase | +75,000 | $2.08 | $156K | 165,372 |
| 2022-02-17 | Alspaugh Jonathan Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +170,000 | 170,000 | ||
| 2021-12-09 | Alspaugh Jonathan Chief Financial Officer | Purchase | +50,000 | $3.72 | $186K | 90,372 |
| 2021-08-18 | Alspaugh Jonathan Chief Financial Officer | Purchase | +7,200 | $6.72 | $48K | 40,372 |
| 2021-08-17 | Alspaugh Jonathan Chief Financial Officer | Purchase | +23,392 | $6.50 | $152K | 33,172 |
| 2021-08-16 | Alspaugh Jonathan Chief Financial Officer | Purchase | +9,780 | $6.37 | $62K | 9,780 |
| 2021-07-06 | Alspaugh Jonathan Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +160,000 | 160,000 |
Page 1 of 1 · 10 trades